HOME  >  Company Introduction

Corporate history

Corporate history

2019  
2019.07 Received grant from Korea Drug Development Fund for GM103
2019.06 Relocated office and research facility of GeneMedicine Co., Ltd.,
2019.05 Received Series A investment
2019.03 Accredited as Corporate R&D Research Center
(Korea Industrial Technology Association)
2015~2018  
2018.12 Received grant from Tech Incubator Program for Startup
2018.04 Accredited as a medium-sized business (Ministry of SMEs and Startups)
2017.01 Accredited as a bioventure (Korea Technology Finance Corporation)
2016.11 Received grant from National Research Foundation of Korea for GM102
2016.09 Licensing out an agreement with US Bio-Tech firm M***
2016.07 Licensing out an agreement with NASDAQ-listed US firm F***
2016.06 Received grant from Korea Drug Development Fund for GM103
~ 2014  
2014.11 GeneMedicine Co., Ltd., established
2008.06 GM101 phase I clinical trial in Korea
TOP